Atlas Trials

COACT Study: CGRPmAbs + OnabotulinumtoxinA Assessment of Chronic Migraine Treatments Study

Clinical trial NCT05724771 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05724771
Sponsor
Chicago Headache Center & Research Institute
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Chronic Migraine, Headache
Start date
2023-01-26
Primary completion
2025-03-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.